Further Identification of CTX-M-2 Extended-Spectrum β-Lactamase in Pseudomonas aeruginosa
- 1 May 2009
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 53 (5) , 2225-2226
- https://doi.org/10.1128/aac.01602-08
Abstract
Hop Bicetre, AP HP, INSERM Emerging Resistance Antibiot, Fac Med,U914, K Bicetre, FranceUniversidade Federal de São Paulo, Lab ALERTA, São Paulo, BrazilUniv Paris 11, K Bicetre, FranceUniversidade Federal de São Paulo, Lab ALERTA, São Paulo, BrazilWeb of SciencKeywords
This publication has 9 references indexed in Scilit:
- Clinically significant carbapenemases: an updateCurrent Opinion in Infectious Diseases, 2008
- Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concernThe Lancet Infectious Diseases, 2008
- Genetic support of extended-spectrum β-lactamasesClinical Microbiology & Infection, 2008
- A CTX-M extended-spectrum β-lactamase in Pseudomonas aeruginosa and Stenotrophomonas maltophiliaJournal of Medical Microbiology, 2006
- Spread of blaCTX-M-type and blaPER-2 β-lactamase genes in clinical isolates from Bolivian hospitalsJournal of Antimicrobial Chemotherapy, 2006
- Dissemination in distinct Brazilian regions of an epidemiccarbapenem-resistant Pseudomonas aeruginosa producing SPM metallo- -lactamaseJournal of Antimicrobial Chemotherapy, 2003
- Ambler Class A Extended-Spectrum β-Lactamases in Pseudomonas aeruginosa : Novel Developments and Clinical ImpactAntimicrobial Agents and Chemotherapy, 2003
- Biochemical Sequence Analyses of GES-1, a Novel Class A Extended-Spectrum β-Lactamase, and the Class 1 Integron In52 from Klebsiella pneumoniaeAntimicrobial Agents and Chemotherapy, 2000
- Factors affecting the isolation of CCC DNA from Streptomyces lividans and Escherichia coliPlasmid, 1984